Lisinopril versus hydrochlorothiazide in obese hypertensive patients: A multicenter placebo-controlled trial

Hypertension

Volumn 30, Issue 1, 1997, Pages 140-145

  Reisin, Efrain ^a   Weir, Matthew R ^b   Falkner, Bonita ^c   Hutchinson, Howard G ^d   Anzalone, Deborah A ^d   Tuck, Michael L ^e  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d ASTRAZENECA   (United Kingdom)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Diuretics; Hypertension obesity

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; LISINOPRIL;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBESITY; PRIORITY JOURNAL;

EID: 0030875549     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.1.140     Document Type: Article

References (23)

1. Hsu PH, Mathewson FA, Rabkin SW. Blood pressure and body mass index patterns: a longitudinal study. J Chronic Dis. 1977;30: 93-113.
2. MacMahon SW, Blacket RB, MacDonald GI, Hall W. Obesity, alcohol consumption and blood pressure in Australian men and women: The National Heart Foundation of Australia Risk Factor Prevalence Study. J Hypertens. 1984;2:85-91.
3. Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med. 1978;298:1-6.
4. Reisin E, Frohlich ED. Effects of weight reduction on arterial pressure. J Chronic Dis. 1982;35:887-891.
5. Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity and plasma aldosterone levels in obese patients. N Engl J Med. 1981; 304:930-933.
6. Langford HG, Davis BR, Oberman A, Wassertheil-Smoller S, Hawkins CM, Zimbaldi N for the TAIM Study Group. Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. Hypertension. 1991;17:210-217.
7. Dornfeld LP, Maxwell MH, Waks AV, Schroth P, Tuck ML. Obesity and hypertension: long-term effect of weight reduction on arterial pressure. Int J Obes. 1985;9:381-389.
8. Stevens VJ, Corrigan SA, Obarzaneck E, Bernaver E, Cook NR, Hebert P, Mattfeldt-Beman M, Oberman A, Sugars C, Dalcin AT, Whelton PK, for the TOHP Collaborative Research Group. Weight loss intervention in phase I of the trials of hypertension prevention. Arch Intern Med. 1993;153:849-858.
9. Dunbar J. Practical aspects of dietary management of hypertension compliance. Can J Physiol Pharmacol. 1986;64:831-835.
10. NIH Technology Assessment Conference Panel. Methods of voluntary weight loss and control. Ann Intern Med. 1992;116:942-949.
11. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-V). Arch Intern Med. 1993;153:154-183.
12. Tuck ML. Role of salt in the control of blood pressure in obesity and diabetes mellitus. Hypertension. 1991;17(suppl I):I-135-I-142.
13. Weir MR, Dengel DR, Behrens MT, Goldberg AP. Salt induces increases in systolic blood pressure effect renal hemodynamics and proteinuria. Hypertension. 1995;25:1339-1344.
14. Messerli FH, Christie B, DeCarvalho JGR, Aristimuno GG, Suarez DH, Dreslinski GR, Frohlich ED. Obesity and essential hypertension: hemodynamics, intravascular volume and plasma renin activity. Arch Intern Med. 1981;141:81-85.
15. Dengel DR, Goldberg AP, Mayuga RS, Kairis GM, Weir MR. Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension. 1996;28:127-132.
16. Frohlich ED. Obesity hypertension: converting enzyme inhibitors and calcium antagonists. Hypertension. 1992;19(suppl I):I-119-I-123.
17. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med. 1989;321: 868-873.
18. Dzau VJ. Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol. 1987;59: 59A-65A.
19. Sanchez RA, Marco E, Gilbert HB, Raffaele GP, Brito M, Gimenez M, Moledo LI. Natriuretic effects and changes in renal hemodynamics induced by enalapril in essential hypertension. Drugs. 1985; 30:149-158.
20. Wilson IM, Freis ED. Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide. Circulation. 1959;20:1028-1036.
21. Frohlich ED, Schnaper HW, Wilson IM, Freis ED. Hemodynamic alterations in hypertensive patients due to chlorothiazide. N Engl J Med. 1960;262:1261-1263.
22. Johnson BF, Saunders R, Hickler R, Marwaha R, Johnson J. The effect of thiazide diuretics upon plasma lipoproteins. J Hypertens. 1986;19:235-239.
23. Reaven GM, Clinkingbeard C, Jeppesen J, Moheux P, Pei D, Foote J, Hollenbeck CB, Chen YDI. Comparison of the hemodynamic and metabolic effect of low dose hydrochlorothiazide and lisinopril treatment in obese patients with high blood pressure. Am J Hypertens. 1995;8:461-466.